Nov 4, 2020 | press release
Saillant Therapeutics meldt succes in preklinisch onderzoek bij de behandeling van hartfalen, met herstel van functie en zelfs regeneratie van de hartspier Nijmegen, 4 november, 2020 — Saillant Therapeutics, een biotechnologiebedrijf in de preklinische fase dat...
Nov 4, 2020 | press release
Saillant Therapeutics Reports Proof of Concept of its Treatment in Heart Failure showing Functional Reversal and Myocardial Rejuvenation Nijmegen, The Netherlands, 4 November, 2020 — Saillant Therapeutics, an innovative preclinical stage biotechnology company...
Aug 14, 2020 | press release
Dutch Saillant Therapeutics to develop generic virus inhibiting therapy based on activation of a cellular master regulator, ending virus replication Nijmegen, The Netherlands, 11 August 2020 — Saillant Therapeutics, an innovative biotechnology start-up,...
Recent Comments